Afreximbank has declared a $300,000 grant to advance haematology research, focusing on critical blood disorders such as leukaemia and sickle cell disease.
The announcement made on Tuesday comes as part of two fresh initiatives developed to transform healthcare across Africa.
Through the Africa
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
